Medtronic's Integrated Diabetes System Makes The Grade In UK
This article was originally published in The Gray Sheet
Executive Summary
The United Kingdom’s National Health Service should adopt Medtronic’s MiniMed Paradigm Veo insulin pump/glucose monitor system over rival systems for patients with type 1 diabetes who experience disabling hypoglycemia, the country's National Institute for Health and Care Excellence recommends.